Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.401
-0.007 (-1.74%)
At close: Nov 20, 2024, 4:00 PM
0.420
+0.019 (4.76%)
Pre-market: Nov 21, 2024, 7:07 AM EST
Entero Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 16.32 | 10.74 | 11.99 | 18.38 | 7.29 | 6.06 | |
| Research & Development | 2.19 | 5.03 | 0.69 | 38.32 | 19.14 | 8.68 | |
| Operating Expenses | 18.51 | 15.77 | 12.68 | 56.7 | 26.43 | 14.74 | |
| Operating Income | -18.51 | -15.77 | -12.68 | -56.7 | -26.43 | -14.74 | |
| Interest Expense | -0.02 | -0.02 | -0.02 | -0.01 | -5.84 | -0.43 | |
| Interest & Investment Income | 0.02 | 0 | 0.01 | 0 | 0 | - | |
| Other Non Operating Income (Expenses) | -0.01 | -0 | -0.23 | -0 | - | - | |
| EBT Excluding Unusual Items | -18.53 | -15.79 | -12.92 | -56.72 | -32.27 | -15.18 | |
| Asset Writedown | - | - | - | -2.35 | - | - | |
| Other Unusual Items | - | - | -1.71 | 0.53 | -0.4 | - | |
| Pretax Income | -18.53 | -15.79 | -14.63 | -58.54 | -32.67 | -15.18 | |
| Net Income | -9.92 | -15.79 | -14.63 | -58.54 | -32.67 | -15.18 | |
| Preferred Dividends & Other Adjustments | 0.23 | 0.31 | 0.34 | 25.98 | 9.06 | - | |
| Net Income to Common | -10.15 | -16.1 | -14.97 | -84.52 | -41.73 | -15.18 | |
| Shares Outstanding (Basic) | 2 | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 2 | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 1324.34% | 836.57% | - | - | - | - | |
| EPS (Basic) | -4.14 | -47.88 | -416.94 | - | - | - | |
| EPS (Diluted) | -4.97 | -47.88 | -416.94 | - | - | - | |
| Free Cash Flow | -12.49 | -12.38 | -22.34 | -32.36 | -11.23 | -14.06 | |
| Free Cash Flow Per Share | -5.10 | -36.80 | -622.19 | - | - | - | |
| EBITDA | -18.46 | -15.74 | -12.65 | -56.16 | -25.87 | -14.11 | |
| D&A For EBITDA | 0.06 | 0.03 | 0.03 | 0.54 | 0.57 | 0.64 | |
| EBIT | -18.51 | -15.77 | -12.68 | -56.7 | -26.43 | -14.74 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.